Dates: December 17th /18th December 2026
Location: Delta Hotels at Marriott Preston, Garstang Road, Preston
Invitation for Abstract Submission
We are now open for abstract submission from 14th August. As before talks will be of 10 minutes duration followed by 5 minutes for questions from the floor. Also, again as with earlier meetings, we are pleased to welcome ‘early stage’ contributions. These will be of short duration, 5 minutes, with 5 minutes for discussion. This latter form will be embedded within a dedicated session designed to aid the presenter with constructive encouragement.
Deadline for abstract submission is 30th October.
Delegates will be informed formally of acceptance of their abstract submission within two weeks of submission.
Please note that Registration will be open from the 1st September and relevant forms will be available on the web site from this time.
Key Speaker: Marion Smits, Professor of Neuroradiology, Erasmus MC – University Medical Centre, Rotterdam Holland. 'AI for Neuro-oncological Imaging'.
Other invited speakers will include:
Paul Brennan (Edinburgh) - 'Emerging Gene Therapies for GBM'.
Petra Hamerlik (Manchester) - 'Liquid Biopsy Proteomics for Non-invasive Detection of Brain Tumours'.
Lucy Stead (Leeds) - 'Understanding Glioblastoma Relapse Through Cellular Adaption.'
TTF Tiger Study Update (Speaker to be confirmed).
Adam Waldman (Edinburgh) - ‘How We Can Use Imaging to do Very Much Better Trials’
Matt Williams, (Imperial, London) - 'Minimal Change Leads to Minimal Results: Interpretating the Results of the TRIDENT trial’
Closing date for registration will be 1st December.
It is our intention this year to open the registration desk on Thursday (17th December) at 9.30 to enable the first session to begin at 10.30.
Please note that we are happy to be able to keep the costs of registration similar to last year.
Please complete the form below and email the abstract to